Skip to main content

Anemia of Cancer and Its Cardiovascular Effects

  • Chapter
Cancer and the Heart
  • 66 Accesses

Abstract

The principal obligation of blood, heart, and vessels is to maintain a steady and optimal oxygen supply to the tissues. These three organs are controlled by closely integrated feedback circuits, and a change in the function in any one will cause compensatory adjustment in the function of the others. In the case of blood, acute reduction in the oxygen-carrying capacity will result in tissue hypoxia, vascular dilatation, and decreased peripheral vascular resistance, which, abetted by lower blood viscosity, will cause an increase in cardiac output and, in turn, restoration to normal of oxygen supply to the tissues. However, such a primary response by the heart to anemia is metabolically and functionally expensive and is saved for conditions of acute and severe life-threatening anemia. In patients with cancer the associated anemia is usually chronic and of moderate severity, and here the compensatory adjustments in oxygen flow rarely demand an increase in cardiac work, but are accomplished by other means, such as changes in oxygen affinity and redistribution of blood among the tissues.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Birgegard G, Hallgren R, Killander A, et al: Serum ferritin during infection. Scand J Haematol 21: 333, 1978.

    Article  PubMed  CAS  Google Scholar 

  2. Applefeld MM, Wiernik PH: Cardiac disease after radiation therapy for Hodgkin’s disease. Analysis of 48 patients. Am J Cardiol 51: 1679, 1983.

    Article  PubMed  CAS  Google Scholar 

  3. Lenaz L, Page JA: Cardiotoxicity of adriamycin and related anthracyclines. Cancer Treat Rev 3: 111, 1976.

    Article  PubMed  CAS  Google Scholar 

  4. Gottdiener JS, Appelbaum FR, Ferrans VJ, et al: Cardiotoxicity associated with high dose cyclophosphamide therapy. Arch Intern Med 141: 758, 1981.

    Article  PubMed  CAS  Google Scholar 

  5. Steinberg LJ, Steinherz PG, Mangiacasale D, et al: Cardiac abnormalities after AMSA administration. Cancer Ther Rep 66: 483, 1982.

    Google Scholar 

  6. Alexander J, Daniak T, Berger HJ, et al: Serial assessment of doxorubicin cardiotoxicity with quantitative radionuclide angiocardiography. N Engl J Med 300: 278, 1978.

    Article  Google Scholar 

  7. Cartwright GE: The anemia of chronic disorders. Semin Hematol 3: 351, 1966.

    PubMed  CAS  Google Scholar 

  8. Lee GR: The anemia of chronic disease. Semin Hematol 20: 61, 1983.

    PubMed  CAS  Google Scholar 

  9. Reizenstein R: Hematologic Stress Syndrome. The Biologic Response to Disease. New York Praeger Scientific, 1984.

    Google Scholar 

  10. Huebers H, Finch CA: Transferrin: Physiologic behavior and clinical implications. Blood 64: 763, 1984.

    PubMed  CAS  Google Scholar 

  11. Douglas SW, Adamson JW: The anemia of chronic disorders: Studies of marrow regulation and iron metabolism. Blood 45: 55, 1975.

    PubMed  CAS  Google Scholar 

  12. Zucker S, Friedman S, Lysik RM: Bone marrow erythropoiesis in the anemia of infection, inflammation and malignancy. J Clin Invest 53: 1132, 1974.

    Article  PubMed  CAS  Google Scholar 

  13. Daniak N, Kulkarni V, Howard D et al: Mechanisms of abnormal erythropoiesis in malignancy. Cancer 51: 1101, 1983.

    Article  Google Scholar 

  14. Dinarello CA: Interleukin-1 and the pathogenesis of the acute-phase response. N Engl J Med 311: 1413, 1984.

    Article  PubMed  CAS  Google Scholar 

  15. Birgens HS: The biologic significance of lactoferrin in haematology. Scand J Haematol 33: 225, 1984.

    Article  PubMed  CAS  Google Scholar 

  16. Broxmeyer, HE: Functional activities of acidic isoferritins and lactoferrin in vitro and in vivo. Blood Cells 10: 397, 1984.

    PubMed  CAS  Google Scholar 

  17. Stryckmans, PA: Lactoferrin. No evidence for its role in the regulations of CSA production by human lymphocytes and monocytes. Blood Cells 10: 369, 1984.

    PubMed  CAS  Google Scholar 

  18. Hansen NE: The anemia of chronic disorders. A bag of unsolved questions. Scand J Haematol 31: 397, 1983.

    Article  PubMed  CAS  Google Scholar 

  19. Weinberg E: Iron and neoplasms. Biol Trace Elem Res 3: 55, 1981.

    Article  CAS  Google Scholar 

  20. Utiger RD: Decreased extrathyroidal triiodothyronine production in nonthyroidal disease. Benefit or harm? Am J Med 69: 860, 1981.

    Google Scholar 

  21. Robin ED: Of men and mitochondrias: Coping with hypoxic dysoxia. Am Rev Respir Dis 122: 517, 1980.

    PubMed  CAS  Google Scholar 

  22. Bellingham AJ, Grimes AJ: Red cell 2,3 diphosphoglycerate. Br J Haematol 25: 555, 1973.

    Article  PubMed  CAS  Google Scholar 

  23. Bradley SE, Bradley GP: Renal function during chronic anemia in man. Blood 2: 192, 1947.

    PubMed  CAS  Google Scholar 

  24. Schrier RW, Earley LE: Effects of hematocrit on renal hemodynamics and sodium excretion in hydropenic and volume-expanded dogs. J Clin Invest 49: 1656, 1970.

    Article  PubMed  CAS  Google Scholar 

  25. Duke M, Abelman WH: The hemodynamic response to chronic anemia. Circulation 39: 503, 1969.

    PubMed  CAS  Google Scholar 

  26. Varat MA, Adolph RJ, Fowler NO: Cardiovascular effects of anemia. Am Heart J 83: 415, 1972.

    Article  PubMed  CAS  Google Scholar 

  27. Rosenthal DS, Handin RJ, Braunwald E: Hematologic-oncologic disorders and heart disease. In Braunwald E (ed): Heart Disease. Philadelphia, WB Saunders, 1984, p 1676.

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1986 Springer-Verlag New York Inc.

About this chapter

Cite this chapter

Erslev, A.J., Caro, J. (1986). Anemia of Cancer and Its Cardiovascular Effects. In: Kapoor, A.S. (eds) Cancer and the Heart. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-4898-9_16

Download citation

  • DOI: https://doi.org/10.1007/978-1-4612-4898-9_16

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-96245-0

  • Online ISBN: 978-1-4612-4898-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics